We are live on ! Find out more
HC

Hampstead Capital Portfolio holdings

AUM $55.8M
1-Year Est. Return 2.76%
This Fund
S&P 500
This Quarter Est. Return
-2.66%
1 Year Est. Return
+2.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$4.95M
Cap. Flow
+$7.24M
Cap. Flow %
7.12%
Top 10 Hldgs %
46.05%
Holding
34
New
5
Increased
7
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
EXC icon
Exelon
EXC
+$3.75M
2
CVX icon
Chevron
CVX
+$3.44M
3
KO icon
Coca-Cola
KO
+$3.31M
4
FLR icon
Fluor
FLR
+$2.25M
5
T icon
AT&T
T
+$1.39M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.28M
2
TWX
Time Warner Inc
TWX
+$1.95M
3
HPE icon
Hewlett Packard
HPE
+$1.24M
4
AAPL icon
Apple
AAPL
+$887K
5
PFE icon
Pfizer
PFE
+$701K

Sector Composition

Rank Sector Weight
1 Healthcare 23.57%
2 Communication Services 15.27%
3 Energy 14.41%
4 Utilities 10.24%
5 Technology 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
1
AT&T
T
$159B
$7.91M 7.78%
277,510
+47,266
+21% +$1.39M
PFE icon
2
Pfizer
PFE
$143B
$6.38M 6.28%
200,260
-22,239
-10% -$701K
VTRS icon
3
Viatris
VTRS
$20.4B
$5.05M 4.97%
130,000
– –
CELG
4
DELISTED
Celgene Corp
CELG
$4.54M 4.47%
35,000
-5,000
-13% -$613K
GILD icon
5
Gilead Sciences
GILD
$162B
$4.32M 4.25%
61,000
+10,000
+20% +$665K
TMUS icon
6
T-Mobile US
TMUS
$185B
$4.24M 4.18%
70,000
– –
EXC icon
7
Exelon
EXC
$47.2B
$3.79M 3.73%
+147,210
New +$3.75M
TEVA icon
8
Teva Pharmaceuticals
TEVA
$40.8B
$3.65M 3.6%
110,000
– –
AAPL icon
9
Apple
AAPL
$4.54T
$3.46M 3.4%
96,000
-24,000
-20% -$887K
MSFT icon
10
Microsoft
MSFT
$3.45T
$3.45M 3.39%
50,000
-10,000
-17% -$686K
RY icon
11
Royal Bank of Canada
RY
$291B
$3.41M 3.35%
47,000
+2,200
+5% +$154K
CVX icon
12
Chevron
CVX
$392B
$3.39M 3.34%
+32,500
New +$3.44M
KO icon
13
Coca-Cola
KO
$377B
$3.36M 3.31%
+75,000
New +$3.31M
VZ icon
14
Verizon
VZ
$195B
$3.36M 3.31%
75,300
+8,700
+13% +$405K
PM icon
15
Philip Morris
PM
$297B
$3.36M 3.31%
28,600
-500
-2% -$57.9K
XOM icon
16
ExxonMobil
XOM
$644B
$3.36M 3.3%
41,600
+1,500
+4% +$123K
PPL
17
PPL Corp
PPL
$26.5B
$3.35M 3.29%
86,600
-1,000
-1% -$38.7K
GM icon
18
General Motors
GM
$80.4B
$3.32M 3.27%
95,000
– –
SO icon
19
Southern Company
SO
$109B
$3.27M 3.22%
68,400
+2,500
+4% +$125K
PXD
20
DELISTED
Pioneer Natural Resource Co.
PXD
$3.19M 3.14%
20,000
– –
RRC icon
21
Range Resources
RRC
$9.38B
$2.78M 2.74%
120,000
– –
WLK icon
22
Westlake Corp
WLK
$9.03B
$2.65M 2.61%
40,000
– –
MOS icon
23
The Mosaic Company
MOS
$7.03B
$2.51M 2.47%
110,000
– –
AIG icon
24
American International
AIG
$41.7B
$2.5M 2.46%
40,000
– –
FLR icon
25
Fluor
FLR
$7.01B
$2.15M 2.12%
+47,000
New +$2.25M
1
2

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
EIC
ENA Investment Capital London, United Kingdom $61.8M AUM
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
BOIA
Bush ODonnell Investment Advisors St Louis, Missouri $65.2M AUM 13.39% 1-Year Est. Return

Hampstead Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Hampstead Capital held 34 positions worth $102M, up 5.1% from $96.7M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Hampstead Capital deployed $7.24M of net new capital in Q2 2017, opening 5 new positions and adding to 7 existing holdings. Its largest new stake was Exelon: 147,210 shares worth $3.79M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 28% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Hewlett Packard, an estimated $1.24M trimmed.

  • Hampstead Capital's largest Q2 2017 buy was Exelon: 147,210 shares worth $3.79M.
  • Hampstead Capital added most to AT&T in Q2 2017, an estimated $1.39M increase.
  • Hampstead Capital's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $1.24M.
  • Hampstead Capital fully exited Merck in Q2 2017, selling an estimated $3.28M.
  • Hampstead Capital's ten largest holdings make up 46% of its $102M portfolio in Q2 2017.
  • Hampstead Capital opened 5 new positions and closed 2 in Q2 2017.
  • Hampstead Capital's portfolio value rose 5.1% quarter-over-quarter to $102M.

Based on Hampstead Capital's 13F filing for Q2 2017, filed 14 Aug 2017.